Search PubMed⌕ Search

Biomedical subjects

G Richardson

Publications and source records attributed to G Richardson.

At least 127 records · Page 7Linked to original sources
PubMed1979

REM sleep episodes during the Multple Sleep Latency Test in narcoleptic patients.

Forty narcoleptic patients were given the Multiple Sleep Latency Test, consisting of 20 min opportunities to sleep offered at 10.00, 12.00, 14.00, 16.00 and 18.00 o'clock. Eleven patients had 2 episodes of REM sleep, 5 had 3, 11 had 4, and 13 had 5 before they were awakened. Fourteen control subjects given similar opportunities to sleep (reported in a companion article (Richardson et al. 1978)) had no REM sleep episodes. For the 10.00-18.00 o'clock opportunities respectively, there were 32, 29, 30, 28 and 27 REM sleep episodes. We conclude that this procedure can provide physicians with data useful in the diagnosis of narcolepsy.

Adult↗
PubMed1979

Effect of treatment on the immunological status of women with advanced breast cancer.

An immunological profile has been serially studied in 72 patients with advanced breast cancer during the course of a randomized trial of chemotherapy and hormonal manipulation. DNCB+ patients were more likely to respond to either therapy, but no other test was predictive of response. In the follow-up period all chemotherapy patients had a reduction in white-cell count which was significantly greater in those responding to treatment. None of the other tests (phytohaemagglutinin response, immunoglobulins G, A and M, or Mantoux test) demonstrated changes that could be related to treatment or response, but there was a gradual unexplained fall in IgM levels in all groups the study progressed. It is concluded that the chemotherapeutic regimen (cyclophosphamide, vincristine, adriamycin and 5-fluorouracil) is relatively non-immunosuppressive, and that hormonal therapy (oophorectomy, tamoxifen or androgens) had no detectable effect on the immune response.

Antibody Formation↗
PubMed1973

The production and testing of staphylococci with clumping factor activity for use in the assay of fibrinogen degradation products.

A method for the large-scale production of a staphylococcal preparation for use in the assay of fibrinogen degradation products is described. The material is assayed against a fibrinogen standard and is shown to be stable over long periods and of high sensitivity. The possibility of production on an occasional basis in a routine laboratory is discussed.

Agglutinins↗